Arizona State Retirement System - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$969,122
-17.7%
21,351
+1.7%
0.01%
-20.0%
Q2 2023$1,178,154
+20.9%
20,986
-2.6%
0.01%
+11.1%
Q1 2023$974,752
+14.7%
21,551
+3.1%
0.01%
+12.5%
Q4 2022$850,032
-35.0%
20,911
+4.6%
0.01%
-42.9%
Q3 2022$1,307,000
+8.2%
19,996
+0.6%
0.01%
+16.7%
Q2 2022$1,208,000
+16.3%
19,876
+20.1%
0.01%
+50.0%
Q1 2022$1,039,000
-16.4%
16,549
+0.9%
0.01%
-11.1%
Q4 2021$1,243,000
-32.7%
16,407
-0.6%
0.01%
-40.0%
Q3 2021$1,848,000
-30.4%
16,511
+0.7%
0.02%
-31.8%
Q2 2021$2,655,000
+26.6%
16,403
-4.7%
0.02%
+22.2%
Q1 2021$2,097,000
-10.3%
17,213
+12.8%
0.02%
-14.3%
Q4 2020$2,337,000
+80.6%
15,262
-1.4%
0.02%
+61.5%
Q3 2020$1,294,000
+97.3%
15,476
+73.4%
0.01%
+44.4%
Q2 2020$656,000
+119.4%
8,927
+26.6%
0.01%
+80.0%
Q1 2020$299,0007,0520.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders